164 related articles for article (PubMed ID: 21500985)
1. Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.
Jwala J; Boddu SH; Shah S; Sirimulla S; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2011 Apr; 27(2):163-72. PubMed ID: 21500985
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
3. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
4. Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.
Yang X; Sheng Y; Ray A; Shah SJ; Trinh HM; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2532-2540. PubMed ID: 25775276
[TBL] [Abstract][Full Text] [Related]
5. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
6. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.
Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK
Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of nanoparticulate formulation of a water soluble prodrug of dexamethasone by HIP complexation.
Gaudana R; Parenky A; Vaishya R; Samanta SK; Mitra AK
J Microencapsul; 2011; 28(1):10-20. PubMed ID: 20939702
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Stereoisomeric Dipeptide Prodrugs of Acyclovir Following Intravenous and Oral Administrations in Rats: A Study Involving In vivo Corneal Uptake of Acyclovir Following Oral Dosing.
Talluri RS; Gaudana R; Hariharan S; Mitra AK
Ophthalmol Eye Dis; 2009; 1():21-31. PubMed ID: 23861607
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
10. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
11. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
Talluri RS; Samanta SK; Gaudana R; Mitra AK
Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
[TBL] [Abstract][Full Text] [Related]
13. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line.
Tak RV; Pal D; Gao H; Dey S; Mitra AK
J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709
[TBL] [Abstract][Full Text] [Related]
14. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.
Dias C; Nashed Y; Atluri H; Mitra A
Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
16. Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement.
Majumdar S; Hingorani T; Srirangam R; Gadepalli RS; Rimoldi JM; Repka MA
Pharm Res; 2009 May; 26(5):1261-9. PubMed ID: 18839288
[TBL] [Abstract][Full Text] [Related]
17. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
18. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.
Vadlapudi AD; Cholkar K; Vadlapatla RK; Mitra AK
J Ocul Pharmacol Ther; 2014 Feb; 30(1):49-58. PubMed ID: 24192229
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]